by telrheum | Mar 23, 2024 | Osteoarthritis, Cell Therapy, Orthopedic
Cell therapies, particularly those using mesenchymal stem cells (MSCs), have been explored for their potential in treating osteoarthritis (OA), offering a more regenerative approach compared to traditional steroid injections. A systematic review and meta-analysis...
by telrheum | Mar 23, 2024 | Biologic Therapy, Psoriatic Arthritis, Rheumatic Drugs, Rheumatoid Arthritis, Spondyloarthritis, Viral Infections
Paxlovid’s Effectiveness Paxlovid, comprised of nirmatrelvir and ritonavir, has been recognized for its effectiveness in treating COVID-19. It works by inhibiting the protease of SARS-CoV-2, preventing the virus from replicating. Studies indicate that it...
by telrheum | Mar 21, 2024 | Biologic Therapy, Rheumatic Drugs, Rheumatoid Arthritis
The presentation of RA typically involves symmetric joint pain, stiffness, and swelling, most commonly affecting the hands, wrists, and feet. The stiffness is often worse in the morning or after periods of inactivity, lasting for more than thirty minutes. RA can also...
by telrheum | Mar 18, 2024 | Rheumatic Drugs, Biologic Therapy, Psoriatic Arthritis, Rheumatoid Arthritis, Spondyloarthritis
Arthritis is a common condition characterized by inflammation of one or more joints, leading to pain, swelling, stiffness, and reduced range of motion. It affects millions of people worldwide and can significantly impact quality of life. There are several types of...
by telrheum | Mar 16, 2024 | Biologic Therapy, Psoriatic Arthritis, Rheumatic Drugs, Spondyloarthritis
Bimekizumab, a novel biologic therapy, is showing promising results in the treatment of psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis (nr-axSpA, M46.80). This medication belongs to a class of drugs known as monoclonal...
